Triton X-100-treated virus-based ELLA demonstrates discordant antigenic evolution of influenza B virus hemagglutinin and neuraminidase
Journal of Virology · 2024
DOI: 10.1128/jvi.01186-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Thi H T Do und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Au…. Hauptthemen laut MEDLINE: Neuraminidase, Influenza B virus, Hemagglutinin Glycoproteins, Influenza Virus, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Morningside Foundation (), DHAC | National Health and Medical Research Council (NHMRC).
Abstract (Originalsprache)
Neuraminidase (NA)-specific antibodies have been associated with protection against influenza and thus NA is considered a promising target for next-generation vaccines against influenza A (IAV) and B viruses (IBV). NA inhibition (NI) by antibodies is typically assessed using an enzyme-linked lectin assay (ELLA). However, ELLA can be confounded by anti-hemagglutinin (anti-HA) antibodies that block NA by steric hindrance (termed HA interference). Although strategies have been employed to overcome HA interference for IAV, similar approaches have not been assessed for IBV. We found that HA interference is common in ELLA using IBV, rendering the technique unreliable. Anti-HA antibodies were not completely depleted from sera by HA-expressing cell lines, and this approach was of limited utility. In contrast, we find that treatment of virions with Triton X-100, but not Tween-20 or ether, efficiently separates the HA and NA components and overcomes interference caused by anti-HA antibodies. We also characterize a panel of recombinant IBV NA proteins that further validated the results from Triton X-100-treated virus-based ELLA. Using these reagents and assays, we demonstrate discordant antigenic evolution between IBV NA and HA over the last 80 years. This optimized ELLA protocol will facilitate further in-depth serological surveys of IBV immunity as well as antigenic characterization of the IBV NA on a larger scale. IMPORTANCE Influenza B viruses (IBVs) contribute to annual epidemics and may cause severe disease, especially in children. Consequently, several approaches are being explored to improve vaccine efficacy, including the addition of neuraminidase (NA). Antigen selection and assessment of serological responses will require a reliable serological assay to specifically quantify NA inhibition (NI). Although such assays have been assessed for influenza A viruses (IAVs), this has not been done of influenza B viruses. Our study identifies a readily applicable strategy to measure the inhibitory activity of neuraminidase-specific antibodies against influenza B virus without interference from anti-hemagglutinin (anti-HA) antibodies. This will aid broader serological assessment of influenza B virus-specific antibodies and antigenic characterization of the influenza B virus neuraminidase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australia.
- Centre for Pathogen Genomics, University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Thi H T Do, Michelle Wille, Adam K Wheatley, Marios Koutsakos
Förderung
- Morningside Foundation ()
- DHAC | National Health and Medical Research Council (NHMRC)
Zitieren
APA
Do, T. H. T., Wille, M., Wheatley, A. K., & Koutsakos, M. (2024). Triton X-100-treated virus-based ELLA demonstrates discordant antigenic evolution of influenza B virus hemagglutinin and neuraminidase. Journal of Virology. https://doi.org/10.1128/jvi.01186-24
Vancouver
Do THT, Wille M, Wheatley AK, Koutsakos M. Triton X-100-treated virus-based ELLA demonstrates discordant antigenic evolution of influenza B virus hemagglutinin and neuraminidase. Journal of Virology. 2024. doi:10.1128/jvi.01186-24
BibTeX
@article{Do2024,
author = {Do, Thi H T and Wille, Michelle and Wheatley, Adam K and Koutsakos, Marios},
title = {Triton X-100-treated virus-based ELLA demonstrates discordant antigenic evolution of influenza B virus hemagglutinin and neuraminidase},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.01186-24}
}
EUVIMED